Hsbc Holdings PLC Intra Cellular Therapies, Inc. Transaction History

Hsbc Holdings PLC

  • $160 Billion
  • Q2 2024

A detailed history of Hsbc Holdings PLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 13,986 shares of ITCI stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,986
Previous 26,678 47.57%
Holding current value
$1.03 Million
Previous $1.85 Million 48.16%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$64.76 - $79.84 $821,933 - $1.01 Million
-12,692 Reduced 47.57%
13,986 $957,000
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $1.4 Million - $1.64 Million
21,692 Added 435.06%
26,678 $1.85 Million
Q4 2023

Feb 12, 2024
BUY
$46.37 - $73.65 $3,153 - $5,008
68 Added 1.38%
4,986 $357,000
Q3 2023

Nov 13, 2023
BUY
$52.09 - $64.1 $65,581 - $80,701
1,259 Added 34.41%
4,918 $256,000
Q2 2023

Aug 11, 2023
BUY
$54.67 - $66.44 $200,037 - $243,103
3,659 New
3,659 $231,000
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $174,252 - $215,295
3,954 New
3,954 $209,000
Q1 2021

May 14, 2021
SELL
$30.8 - $39.51 $279,910 - $359,066
-9,088 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$23.34 - $32.22 $212,113 - $292,815
9,088 New
9,088 $288,000
Q3 2020

Nov 12, 2020
SELL
$17.61 - $31.86 $210,263 - $380,408
-11,940 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $171,339 - $318,081
11,940 New
11,940 $306,000
Q4 2019

Feb 14, 2020
SELL
$7.26 - $38.49 $266,108 - $1.41 Million
-36,654 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$7.47 - $14.03 $273,805 - $514,255
36,654 New
36,654 $274,000
Q4 2018

Feb 13, 2019
SELL
$10.36 - $20.96 $500,978 - $1.01 Million
-48,357 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$17.77 - $22.9 $653,776 - $842,513
36,791 Added 318.1%
48,357 $1.05 Million
Q2 2018

Aug 10, 2018
SELL
$17.33 - $23.4 $1.44 Million - $1.95 Million
-83,242 Reduced 87.8%
11,566 $204,000
Q1 2018

May 11, 2018
BUY
$15.16 - $25.49 $1.44 Million - $2.42 Million
94,808 New
94,808 $2 Million

Others Institutions Holding ITCI

# of Institutions
400
Shares Held
87.2M
Call Options Held
309K
Put Options Held
302K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email